628 related articles for article (PubMed ID: 18789118)
21. Shoulder ultrasound in dialysis related amyloidosis.
McMahon LP; Radford J; Dawborn JK
Clin Nephrol; 1991 May; 35(5):227-32. PubMed ID: 1855331
[TBL] [Abstract][Full Text] [Related]
22. Chronic dialysis in patients with systemic amyloidosis: the experience in northern Italy.
Moroni G; Banfi G; Montoli A; Bucci A; Bertani T; Ravelli M; Pozzi C; Leonelli M; Lupo A; Volpi A
Clin Nephrol; 1992 Aug; 38(2):81-5. PubMed ID: 1516284
[TBL] [Abstract][Full Text] [Related]
23. Comparison of changes in pulse wave velocity in patients on continuous ambulatory peritoneal dialysis and hemodialysis one year after introduction of dialysis therapy.
Mimura T; Takenaka T; Kanno Y; Aoki H; Ohshima J; Suzuki H
Adv Perit Dial; 2005; 21():139-45. PubMed ID: 16686305
[TBL] [Abstract][Full Text] [Related]
24. Impact of dialysis duration and glucose absorption on nutritional indices in stable continuous ambulatory peritoneal dialysis patients.
Pajek J; Gucek A; Kveder R; Bucar-Pajek M; Kaplan-Pavlovcic S; Bren AF
J Ren Nutr; 2008 Nov; 18(6):503-8. PubMed ID: 18940653
[TBL] [Abstract][Full Text] [Related]
25. [Amyloidosis associated with chronic hemodialysis. The prognostic significance of beta 2-microglobulin changes in patients with terminal chronic kidney failure treated by repeated hemodialysis].
Manasia M; Meseşan M; Gherman-Căprioară M; Malide D; Paţiu IM; Pârvu L; Vlăduţiu D; Spânu CS
Med Interna; 1991; 43(1-2):129-34. PubMed ID: 1670118
[TBL] [Abstract][Full Text] [Related]
26. Significance of brain natriuretic peptides in patients on continuous ambulatory peritoneal dialysis.
Nakatani T; Naganuma T; Masuda C; Uchida J; Sugimura T; Sugimura K
Int J Mol Med; 2002 Oct; 10(4):457-61. PubMed ID: 12239593
[TBL] [Abstract][Full Text] [Related]
27. Effect of dialysis modalities on gastric myoelectrical activity in end-stage renal disease patients.
Lee SW; Song JH; Kim GA; Yang HJ; Lee KJ; Kim MJ
Am J Kidney Dis; 2000 Sep; 36(3):566-73. PubMed ID: 10977789
[TBL] [Abstract][Full Text] [Related]
28. Salivary beta2-microglobulin analysis in chronic kidney disease and hemodialyzed patients.
Michelis R; Sela S; Ben-Zvi I; Nagler RM
Blood Purif; 2007; 25(5-6):505-9. PubMed ID: 18187941
[TBL] [Abstract][Full Text] [Related]
29. Peritoneal dialysis versus hemodialysis: a five-year comparison of survival and effects on the cardiovascular system, erythropoiesis, and calcium metabolism.
Suzuki T; Kanno Y; Nakamoto H; Okada H; Sugahara S; Suzuki H
Adv Perit Dial; 2003; 19():148-54. PubMed ID: 14763052
[TBL] [Abstract][Full Text] [Related]
30. Comparison of shoulder Magnetic Resonance Imaging findings between patients with stage 4 chronic kidney disease and hemodialysis patients with healthy controls.
Turk AC; Fidan N; Ozcan O; Ozkurt S; Musmul A; Sahin F
J Back Musculoskelet Rehabil; 2020; 33(2):179-184. PubMed ID: 31450486
[TBL] [Abstract][Full Text] [Related]
31. Remarkable improvement of activity by CAPD in a hemodialysis patient with a pseudotumor of the craniocervical junction.
Hatakeyama A; Fujinaga H; Togo T; Tamura T; Ozawa K; Shoji T; Sasaoka T
Adv Perit Dial; 1992; 8():116-9. PubMed ID: 1361765
[TBL] [Abstract][Full Text] [Related]
32. Comparison of survival in CAPD and hemodialysis: a multicenter study.
Lupo A; Cancarini G; Catizone L; Cocchi R; de Vecchi A; Viglino G; Salomone M; Segoloni G; Giangrande A; Limido A
Adv Perit Dial; 1992; 8():136-40. PubMed ID: 1361770
[TBL] [Abstract][Full Text] [Related]
33. Increased plasma lipoprotein(a) in continuous ambulatory peritoneal dialysis is related to peritoneal transport of proteins and glucose.
Heimbürger O; Stenvinkel P; Berglund L; Tranoeus A; Lindholm B
Nephron; 1996; 72(2):135-44. PubMed ID: 8684516
[TBL] [Abstract][Full Text] [Related]
34. [Evaluation of serum sialic acid concentration in chronic renal failure children on continuous ambulatory peritoneal dialysis and hemodialysis].
Szprynger K; Szczepańska M; Mazur B; Dyduch A; Zwolińska D; Morawiec-Knysak A; Makulska I
Pol Merkur Lekarski; 2000 Jul; 8(49):459-61. PubMed ID: 11070713
[TBL] [Abstract][Full Text] [Related]
35. CAPD, an acceptable form of therapy in elderly ESRD patients: a comparative study.
Baek MY; Kwon TH; Kim YL; Cho DK
Adv Perit Dial; 1997; 13():158-61. PubMed ID: 9360673
[TBL] [Abstract][Full Text] [Related]
36. Dialysis methods may affect carotid intima-media thickness in Chinese end-stage renal disease patients.
Shi Z; Zhu M; Guan J; Chen J; He Q; Zhang X; Zhu S; Song X; Wang X; Jiang Z
Ren Fail; 2012; 34(10):1206-11. PubMed ID: 23009226
[TBL] [Abstract][Full Text] [Related]
37. The effects of hemodialysis and peritoneal dialysis on serum homocysteine and C-reactive protein levels.
Borazan A; Aydemir S; Sert M; Yilmaz A
Mediators Inflamm; 2004 Dec; 13(5-6):361-4. PubMed ID: 15770053
[TBL] [Abstract][Full Text] [Related]
38. Beta-2 microglobulin levels in hemodialysis patients.
Mumtaz A; Anees M; Bilal M; Ibrahim M
Saudi J Kidney Dis Transpl; 2010 Jul; 21(4):701-6. PubMed ID: 20587875
[TBL] [Abstract][Full Text] [Related]
39. [Beta 2-microglobulin--its role in renal failure and hemodialysis therapy].
Czyz W; Szepietowski T
Postepy Hig Med Dosw; 1992; 46(2):209-38. PubMed ID: 1470582
[TBL] [Abstract][Full Text] [Related]
40. Increased levels of serum matrix metalloproteinase-3 in haemodialysis patients with dialysis-related amyloidosis.
Naganuma T; Sugimura K; Uchida J; Tashiro K; Yoshimura R; Takemoto Y; Nakatani T
Nephrology (Carlton); 2008 Apr; 13(2):104-8. PubMed ID: 18275497
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
